Toggle navigation
Home
Search
Services
Blog
Contact
About
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A.
Weill Medical College of Cornell University, New York, NY, United States
Search 7 grants from Michelle Lane
Search grants from Weill Medical College of Cornell University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Role of Mast Cells in the Pathophysiology of Intracranial Aneurysm
Brainstem Mechanisms of REM Sleep
Dose Escalation of Dmp 777 Lung Specific Bioefficacy in Adult Cf Pts
Atrial Fibrillation Follow Up Investigation of Rhythm Management (Affirm)
Recently added grants:
TMS-EEG investigation of prefrontal cortical excitability in depression and rTMS treatment response
Medicaid Value Based Payment Models and Healthcare Equity for Adults with Serious Mental Illnesses
Basal Ganglia Cortical Coupling and Connectivity Changes in PD and DBS
Neural Basis of Behavioral Arousal
Synaptic Function within Mature Central Pain Networks after Neonatal Injury
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA075722-03
Application #
6172700
Study Section
Special Emphasis Panel (ZRG2-SSS-1 (01))
Program Officer
Lohrey, Nancy
Project Start
2000-08-10
Project End
Budget Start
2000-08-10
Budget End
2001-07-31
Support Year
3
Fiscal Year
2000
Total Cost
$40,013
Indirect Cost
Institution
Name
Weill Medical College of Cornell University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Related projects
NIH 2000
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
$40,013
NIH 1999
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
NIH 1998
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
Publications
Lane, Michelle A; Xu, Juliana; Wilen, Elana W et al.
(2008)
LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol.
Mol Cell Endocrinol 280:63-74
Comments
Be the first to comment on Michelle Lane's grant